Cholesterol myristate
Cat. No.:YN360972
产品名称: | Cholesterol myristate |
CAS No.: | 1989-52-2 |
Chemical Name: | (3β)-cholest-5-en-3-ol 3-tetradecanoate |
Synonyms: | 胆固醇肉豆蔻酸; Cholesteryl myristate; Cholesteryl tetradecanoate |
分子量: | 597.01 |
分子式: | C₄₁H₇₂O₂ |
SMILES: | C[C@@]12[C@]3([H])[C@](CC=C1C[C@@H](OC(CCCCCCCCCCCCC)=O)CC2)([H])[C@@]4([H])[C@@](C)([C@]([C@H](C)CCCC(C)C)([H])CC4)CC3 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Cholesterol myristate 是中药中天然类固醇。Cholesterol myristate 与多种离子通道结合,例如nAChR,GABAA receptor和内向整流钾离子通道 (potassium ion channel)。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Kim, E.J., Kim, B.H., Seo, H.S., et al.Cholesterol-induced non-alcoholic fatty liver disease and atherosclerosis aggravated by systemic inflammationPLoS One5(6),e97841(2014)
Meikle, P.J., Wong, G., Tsorotes, D., et al.Plasma lipidomic analysis of stable and unstable coronary artery diseaseArterioscler. Thromb. Vasc. Biol.31(11),2723-2732(2011)
Rosenblatt, K.M., and Bunjes, H.Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loadingEur. J. Pharm. Biopharm.117,49-59(2017)